The Computational Anatomy of Psychosis
暂无分享,去创建一个
[1] K. Cheng. Theory of Superconductivity , 1948, Nature.
[2] J. Lochner,et al. Form of the Loudness Function in the Presence of Masking Noise , 1961 .
[3] C. Dolea,et al. World Health Organization , 1949, International Organization.
[4] A. M. Richards. Monaural loudness functions under masking. , 1968, The Journal of the Acoustical Society of America.
[5] B. Maher,et al. Delusional thinking and perceptual disorder. , 1974, Journal of individual psychology.
[6] J. Peto,et al. Molecular pathology of schizophrenia: more than one disease process? , 1980 .
[7] Geoffrey E. Hinton,et al. Parallel visual computation , 1983, Nature.
[8] H. Denber. The electrophysiology of schizophrenia , 1986, Biological Psychiatry.
[9] T. Crow,et al. The Relative Stability of Positive and Negative Features in Chronic Schizophrenia , 1987, British Journal of Psychiatry.
[10] P. Liddle. The Symptoms of Chronic Schizophrenia , 1987, British Journal of Psychiatry.
[11] R. Faull,et al. Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites , 1989, Neuroscience.
[12] B T Hyman,et al. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.
[13] F. Benes,et al. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. , 1991, Archives of general psychiatry.
[14] P. Goldman-Rakic,et al. Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390 , 1991, Neuroscience.
[15] D. J. Felleman,et al. Distributed hierarchical processing in the primate cerebral cortex. , 1991, Cerebral cortex.
[16] D. Campion,et al. SPEM impairment in drug-naive schizophrenic patients: Evidence for a trait marker , 1992, Biological Psychiatry.
[17] D Mumford,et al. On the computational architecture of the neocortex. II. The role of cortico-cortical loops. , 1992, Biological cybernetics.
[18] Geoffrey E. Hinton,et al. Keeping the neural networks simple by minimizing the description length of the weights , 1993, COLT '93.
[19] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[20] W. Roth,et al. ERPs for infrequent omissions and inclusions of stimulus elements. , 1994, Psychophysiology.
[21] P. Weiden,et al. Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia , 1994, Psychiatry Research.
[22] Alan C. Evans,et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. G. Feldman,et al. The origin and use of positional frames of reference in motor control , 1995, Behavioral and Brain Sciences.
[24] Geoffrey E. Hinton,et al. The Helmholtz Machine , 1995, Neural Computation.
[25] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[26] N. Perrone-Bizzozero,et al. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Glantz,et al. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.
[29] T. Sharma,et al. Memory and intellectual deficits do not decline with age in schizophrenia , 1997, Schizophrenia Research.
[30] L. Glantz,et al. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.
[31] H. Yabe,et al. Temporal window of integration revealed by MMN to sound omission , 1997, Neuroreport.
[32] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Goldman-Rakic,et al. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.
[34] J. Krystal,et al. The NMDA antagonist model for schizophrenia: promise and pitfalls. , 1998, Pharmacopsychiatry.
[35] Hollis T. Cline,et al. Glutamate Receptor Activity Is Required for Normal Development of Tectal Cell Dendrites In Vivo , 1998, The Journal of Neuroscience.
[36] C Kennard,et al. Smooth pursuit and saccadic abnormalities in first-episode schizophrenia , 1998, Psychological Medicine.
[37] A. Radant,et al. Does Ketamine-Mediated N-methyl-D-aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities? , 1998, Neuropsychopharmacology.
[38] Karl J. Friston,et al. Psychosis and the Experience of Self: Brain Systems Underlying Self‐Monitoring , 1998, Annals of the New York Academy of Sciences.
[39] D. Wolpert,et al. Central cancellation of self-produced tickle sensation , 1998, Nature Neuroscience.
[40] K. Jellinger,et al. The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.
[41] Karl J. Friston,et al. The Relationship Between Synchronization Among Neuronal Populations and Their Mean Activity Levels , 1999, Neural Computation.
[42] P. Garety,et al. Cognitive approaches to delusions: a critical review of theories and evidence. , 1999, The British journal of clinical psychology.
[43] A. Muzet,et al. Electroencephalographic Characterization of Brain Dopaminergic Stimulation by Apomorphine in Healthy Volunteers , 1999, Neuropsychobiology.
[44] Robert W. Buchanan,et al. Smooth pursuit eye movements to extra-retinal motion signals: deficits in patients with schizophrenia , 1999, Psychiatry Research.
[45] A. Borst. Seeing smells: imaging olfactory learning in bees , 1999, Nature Neuroscience.
[46] A. Carlsson,et al. Neurotransmitter interactions in schizophrenia—therapeutic implications , 1999, Biological Psychiatry.
[47] C. Tamminga,et al. Ketamine Effects on Eye Movements , 2000, Neuropsychopharmacology.
[48] P. Kalus,et al. The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients , 2000, Neuroreport.
[49] D. Lewis,et al. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.
[50] T. Schneider-Axmann,et al. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality , 2000, Biological Psychiatry.
[51] D. Javitt,et al. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.
[52] Emilio Salinas,et al. Gain Modulation A Major Computational Principle of the Central Nervous System , 2000, Neuron.
[53] A. Sampson,et al. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.
[54] A. Fanous,et al. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. , 2001, Archives of general psychiatry.
[55] J. Pierri,et al. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. , 2001, The American journal of psychiatry.
[56] J. Coyle,et al. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.
[57] V. Piëch,et al. Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons , 2001, Nature Neuroscience.
[58] J. Jolles,et al. The Neuropsychology of Schizophrenia , 2019 .
[59] Bob Oranje,et al. Modulating sensory gating in healthy volunteers The effects of ketamine and haloperidol , 2002, Biological Psychiatry.
[60] R. Laje,et al. Diversity within a birdsong. , 2002, Physical review letters.
[61] D. Rosielle,et al. Psychiatry , 1905, NeuroImage.
[62] R. Laje,et al. Neuromuscular control of vocalizations in birdsong: a model. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.
[63] C. Salum,et al. The effect of amphetamine on Kamin blocking and overshadowing , 2003, Behavioural pharmacology.
[64] H. Emrich,et al. Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man , 2003, Journal of psychopharmacology.
[65] Karl J. Friston,et al. Dynamic causal modelling , 2003, NeuroImage.
[66] S. Kapur. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.
[67] W. Shi,et al. Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine , 2003, Journal of Pharmacology and Experimental Therapeutics.
[68] D. Wolpert,et al. Two Eyes for an Eye: The Neuroscience of Force Escalation , 2003, Science.
[69] W. A. Phillips,et al. Where the rubber meets the road: The importance of implementation , 2003, Behavioral and Brain Sciences.
[70] H. Westenberg,et al. Increasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating , 2004, Journal of psychopharmacology.
[71] G. Teskey,et al. Induction of long‐term depression is associated with decreased dendritic length and spine density in layers III and V of sensorimotor neocortex , 2004, Synapse.
[72] D. Mumford. On the computational architecture of the neocortex , 2004, Biological Cybernetics.
[73] H. Haken. Synergetics: Introduction and Advanced Topics , 2004 .
[74] J. Montgomery,et al. Discrete synaptic states define a major mechanism of synapse plasticity , 2004, Trends in Neurosciences.
[75] Patricia S. Goldman-Rakic,et al. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction , 2004, Psychopharmacology.
[76] Victor Vostrikov,et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. , 2004, The American journal of psychiatry.
[77] L. Elliot Hong,et al. Response to unexpected target changes during sustained visual tracking in schizophrenic patients , 2005, Experimental Brain Research.
[78] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[79] H. Beckmann,et al. Prenatal developmental disturbances in the limbic allocortex in schizophrenics , 2005, Journal of Neural Transmission.
[80] David A Lewis,et al. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.
[81] Karl J. Friston. Hallucinations and perceptual inference , 2005, Behavioral and Brain Sciences.
[82] Michael J. Frank,et al. Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Nonmedicated Parkinsonism , 2005, Journal of Cognitive Neuroscience.
[83] J. Kao,et al. Long-term potentiation of exogenous glutamate responses at single dendritic spines. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[84] A. Young,et al. The role of dopamine in conditioning and latent inhibition: What, when, where and how? , 2005, Neuroscience & Biobehavioral Reviews.
[85] D. Wolpert,et al. Evidence for sensory prediction deficits in schizophrenia. , 2005, The American journal of psychiatry.
[86] C. Cepeda,et al. Where Do You Think You Are Going? The NMDA-D1 Receptor Trap , 2006, Science's STKE.
[87] Karl J. Friston,et al. Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.
[88] John Suckling,et al. Cerebral Cortex Advance Access published October 26, 2005 The Structural Brain Correlates of Neurological Soft Signs in Healthy Individuals , 2022 .
[89] P. Uhlhaas,et al. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later , 2007, Journal of psychopharmacology.
[90] J. Krystal,et al. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study , 2008, Psychopharmacology.
[91] F. Razoux,et al. Ketamine, at a Dose that Disrupts Motor Behavior and Latent Inhibition, Enhances Prefrontal Cortex Synaptic Efficacy and Glutamate Release in the Nucleus Accumbens , 2007, Neuropsychopharmacology.
[92] T. Baldeweg,et al. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. , 2007, Psychopharmacology.
[93] T. Baldeweg,et al. Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects , 2007, Psychopharmacology.
[94] Paul Allen,et al. Inner speech models of auditory verbal hallucinations: Evidence from behavioural and neuroimaging studies , 2007, International review of psychiatry.
[95] Robert A. Sweet,et al. Anatomical Evidence of Impaired Feedforward Auditory Processing in Schizophrenia , 2007, Biological Psychiatry.
[96] Karl J. Friston. Hierarchical Models in the Brain , 2008, PLoS Comput. Biol..
[97] Deniz S. Ones,et al. Eye movement dysfunction in first-degree relatives of patients with schizophrenia: A meta-analytic evaluation of candidate endophenotypes , 2008, Brain and Cognition.
[98] J. Sweeney,et al. Pharmacological treatment effects on eye movement control , 2008, Brain and Cognition.
[99] G. O'driscoll,et al. Smooth pursuit in schizophrenia: A meta-analytic review of research since 1993 , 2008, Brain and Cognition.
[100] D. Javitt,et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia , 2008, Trends in Neurosciences.
[101] B. Dawant,et al. Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects , 2009, Biological Psychiatry.
[102] Karl J. Friston,et al. Frontiers in Neuroinformatics , 2022 .
[103] Daniel Durstewitz,et al. Implications of synaptic biophysics for recurrent network dynamics and active memory , 2009, Neural Networks.
[104] Karl J. Friston,et al. Reinforcement Learning or Active Inference? , 2009, PloS one.
[105] S. Kapur,et al. The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.
[106] Karl J. Friston,et al. Predictive coding under the free-energy principle , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[107] Karl J. Friston,et al. Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring , 2009, Schizophrenia bulletin.
[108] Heinrich Lanfermann,et al. Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling , 2009, NeuroImage.
[109] Karl J. Friston. The free-energy principle: a rough guide to the brain? , 2009, Trends in Cognitive Sciences.
[110] Karl J. Friston,et al. Cortical circuits for perceptual inference , 2009, Neural Networks.
[111] ChrisD . Frith,et al. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia , 2009, Nature Reviews Neuroscience.
[112] P. Dayan,et al. A Bayesian formulation of behavioral control , 2009, Cognition.
[113] S. Lawrie,et al. Associative learning and the genetics of schizophrenia , 2009, Trends in Neurosciences.
[114] Eleanor H. Simpson,et al. A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia , 2010, Neuron.
[115] Edward M. Hubbard,et al. Superior size–weight illusion performance in patients with schizophrenia: Evidence for deficits in forward models , 2010, Schizophrenia Research.
[116] L. Krabbendam,et al. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. , 2010, The Journal of clinical psychiatry.
[117] Karl J. Friston,et al. Attention, Uncertainty, and Free-Energy , 2010, Front. Hum. Neurosci..
[118] Karl J. Friston,et al. Dynamic causal modeling , 2010, Scholarpedia.
[119] Karl J. Friston,et al. Action and behavior: a free-energy formulation , 2010, Biological Cybernetics.
[120] Danai Dima,et al. Impaired top-down processes in schizophrenia: A DCM study of ERPs , 2010, NeuroImage.
[121] D. Wolpert,et al. Deficits in sensory prediction are related to delusional ideation in healthy individuals , 2010, Neuropsychologia.
[122] Karl J. Friston,et al. Generalised Filtering , 2010 .
[123] P. Mamassian,et al. A New Look at Sensory Attenuation , 2010, Psychological science.
[124] D. Javitt,et al. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? , 2010, Brain Research Bulletin.
[125] P. Mamassian,et al. A New Look at Sensory Attenuation: Action-Effect Anticipation Affects Sensitivity, Not Response Bias , 2010 .
[126] T. Woodward,et al. The contribution of hypersalience to the "jumping to conclusions" bias associated with delusions in schizophrenia. , 2010, Journal of psychiatry & neuroscience : JPN.
[127] Karl J. Friston,et al. An In Vivo Assay of Synaptic Function Mediating Human Cognition , 2011, Current Biology.
[128] P. Fletcher,et al. Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference , 2011, Neuropsychopharmacology.
[129] Brian P Keane,et al. Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010. , 2011, Schizophrenia bulletin.
[130] Joachim M. Buhmann,et al. Generative Embedding for Model-Based Classification of fMRI Data , 2011, PLoS Comput. Biol..
[131] P. Dayan,et al. Bayesian modelling of Jumping-to-Conclusions bias in delusional patients , 2011, Cognitive neuropsychiatry.
[132] F. Waters,et al. Dexamphetamine effects on separate constructs in the rubber hand illusion test , 2011, Psychopharmacology.
[133] Danielle C. Turner,et al. Exploring the Impact of Ketamine on the Experience of Illusory Body Ownership , 2011, Biological Psychiatry.
[134] P. McGuire,et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis , 2011, Molecular Psychiatry.
[135] R. Dolan,et al. Metacognition: computation, biology and function , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.
[136] O. Howes,et al. Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use , 2012, Psychopharmacology.
[137] S. Sherman,et al. Modulatory Effects of Metabotropic Glutamate Receptors on Local Cortical Circuits , 2012, The Journal of Neuroscience.
[138] Karl J. Friston,et al. Predictions not commands: active inference in the motor system , 2012, Brain Structure and Function.
[139] R. Murray,et al. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. , 2012, The American journal of psychiatry.
[140] Karl J. Friston,et al. Smooth Pursuit and Visual Occlusion: Active Inference and Oculomotor Control in Schizophrenia , 2012, PloS one.
[141] Erich Seifritz,et al. Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments , 2012, Neuropsychopharmacology.
[142] Karl J. Friston,et al. Canonical Microcircuits for Predictive Coding , 2012, Neuron.
[143] D. Burr,et al. When the world becomes ‘too real’: a Bayesian explanation of autistic perception , 2012, Trends in Cognitive Sciences.
[144] Bart Verheij,et al. Jumping to Conclusions - A Logico-Probabilistic Foundation for Defeasible Rule-Based Arguments , 2012, JELIA.
[145] Daniel H. Mathalon,et al. Glutamatergic Modulation of Auditory Information Processing in the Human Brain , 2012, Biological Psychiatry.
[146] N. Swerdlow,et al. Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes , 2012, PloS one.
[147] Raymond J. Dolan,et al. Dopamine, Affordance and Active Inference , 2012, PLoS Comput. Biol..
[148] D. Lewis,et al. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. , 2012, Schizophrenia bulletin.
[149] Robert E. Hampson,et al. Columnar Processing in Primate pFC: Evidence for Executive Control Microcircuits , 2012, Journal of Cognitive Neuroscience.
[150] Janet B W Williams. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[151] Thomas V Papathomas,et al. Reduced depth inversion illusions in schizophrenia are state-specific and occur for multiple object types and viewing conditions. , 2013, Journal of abnormal psychology.
[152] J. Feldon,et al. Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice , 2013, Science.
[153] Karl J. Friston,et al. Active inference, sensory attenuation and illusions , 2013, Cognitive Processing.
[154] Karl J. Friston,et al. False perceptions & false beliefs : Understanding schizophrenia , 2013 .
[155] Schizophrenia: The Final Frontier. A Festschrift for Robin M. Murray , 2013, British Journal of Psychiatry.
[156] H. Gibbins,et al. Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia , 2001, Psychopharmacology.